Open AccessPrevalence and Treatment Outcome of Cervicitis of Unknown Etiology
Author(s) -
Stephanie N. Taylor,
Shelly Lensing,
Jane R. Schwebke,
Rebecca Lillis,
Leandro Mena,
Anita L. Nelson,
Anne Rinaldi,
Lisa Saylor,
Linda M. McNeil,
Jeannette Lee
Publication year - 2013
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0b013e31828bfcb1
Subject(s) - medicine , etiology , cervicitis , placebo , clinical trial , cervix , surgery , gynecology , pathology , cancer , alternative medicine
Mucopurulent cervicitis (MPC) is a clinical syndrome characterized by mucopurulent discharge from the cervix and other signs of inflammation. This was a phase III, multicenter study designed to evaluate the effectiveness of placebo versus empiric antibiotic treatment for clinical cure of MPC of unknown etiology at 2-month follow-up. Unfortunately, enrollment was terminated because of low accrual of women with cervicitis of unknown etiology, but important prevalence and outcome data were obtained.